​Mike specializes in Life Sciences R&D, Regulatory and Quality transformation. He brings 7 years of experience across several industries, including Pharmaceutical, MedTech, BioTech, and Medical Device companies. Prior to joining Scimitar, Mike served as a Manager at Deloitte, where he led critical life science initiatives over his tenure.

​Mike has delivered on projects related to the improvement of business processes within the Regulatory, Quality, and R&D spaces for medical device and pharmaceutical clients and the development / management of E2E remediation processes for a pharmaceutical client in response to global regulator’s recognition of health-adverse impurities present in various products within their portfolio. He has also supported various Pharmaceutical / Medical Device companies throughout the entirety of the M&A transaction lifecycle, from pre-deal diligence to post-deal integration. Additionally, Mike has supported cross-functional reporting and analytics teams for Pharmaceutical clients, acting as a strategic business advisor to ensure developed solutions fit business needs. Mike has 2 years of experience as a Life Sciences intellectual property advisor, working with multiple Fortune 500 companies.